Cost-Effectiveness Analysis of Chatbot-Supported Remote Patient Monitoring for Anticoagulation Management: Health Economic Evaluation Within a Pilot Crossover Trial
Ana Rita Santos, Filipa Sampaio, Federico Guede-Fernández, Julian Perelman, Ana Londral · 2026
Read Cost-Effectiveness Analysis of Chatbot-Supported Remote Patient Monitoring for Anticoagulation Management: Health Economic Evaluation Within a Pilot Crossover Trial by Ana Rita Santos, Filipa Sampaio, Federico Guede-Fernández, Julian Perelman, Ana Londral (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13274966.txt.
Description
Ana Rita Santos and colleagues report a 2026 health economics study testing whether chatbot-supported home monitoring of blood-thinning treatment is worth its cost. The pilot crossover trial involved nineteen Portuguese cardiac surgery patients on vitamin K antagonists, who each spent six months on usual care and six on the digital system in random order. The system paired home clotting self-tests with a rule-based chatbot.
Within the same patients, remote monitoring raised the share of time their blood thinning stayed in the target range by 10.43 percentage points. It cost about one hundred ninety-nine euros more per patient from the health service's view, and about two hundred seventy euros from a wider societal view. The analysis was framed as an early feasibility exercise for fuller trials.
Catalog record
| CREATOR | Ana Rita Santos, Filipa Sampaio, Federico Guede-Fernández, Julian Perelman, Ana Londral |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50852 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |